-
公开(公告)号:KR820000741B1
公开(公告)日:1982-05-03
申请号:KR810004879
申请日:1981-12-12
Applicant: FUJISAWA PHARMACEUTICAL CO
IPC: C07D501/36
-
公开(公告)号:DK431480A
公开(公告)日:1981-04-13
申请号:DK431480
申请日:1980-10-10
Applicant: FUJISAWA PHARMACEUTICAL CO
IPC: C07D20060101 , C07D
-
公开(公告)号:DK502078A
公开(公告)日:1979-05-15
申请号:DK502078
申请日:1978-11-10
Applicant: FUJISAWA PHARMACEUTICAL CO
IPC: C07D213/55 , A61K31/545 , A61K31/546 , A61P31/04 , C07D213/73 , C07D213/75 , C07D213/79 , C07D213/80 , C07D239/42 , C07D239/46 , C07D501/20 , C07D501/22 , C07D501/34 , C07D501/36 , C07D501/57 , C07D501/59 , C07D519/06 , C07F7/10 , C07D
Abstract: A novel compound, useful as an intermediate in the production of compounds of high antimicrobial activity, of the formula: wherein Ra1 is hydrogen, amino or a protected amino group, Rb1 and Rc1 are each hydrogen, halogen, lower alkoxy or arylthio, R14 is carboxy or a protected carboxy group, X is lower alkylene or a group of the formula: in which R6 is hydrogen or an organic residue which may have suitable substituent(s), and Z is N or CH, or a salt thereof.
-
4.
公开(公告)号:ZA7701060B
公开(公告)日:1978-01-25
申请号:ZA7701060
申请日:1977-02-22
Applicant: FUJISAWA PHARMACEUTICAL CO
IPC: C07D277/20 , A61K31/545 , A61K31/546 , A61P31/04 , C07C20060101 , C07D277/34 , C07D277/40 , C07D501/20 , C07D501/22 , C07D501/34 , C07D501/36 , C07D501/46 , C07C
CPC classification number: Y02P20/55
-
公开(公告)号:SE437832B
公开(公告)日:1985-03-18
申请号:SE7702547
申请日:1977-03-07
Applicant: FUJISAWA PHARMACEUTICAL CO
IPC: A61K31/545 , A61K31/546 , A61P31/04 , C07D277/20 , C07D277/32 , C07D277/34 , C07D277/38 , C07D277/40 , C07D277/44 , C07D277/46 , C07D277/48 , C07D277/52 , C07D501/20 , C07D501/22 , C07D501/34 , C07D501/36
Abstract: Antibiotic cephalosporin compounds, method of making and pharmaceutical composition thereof represented by the general formula wherein R1 is amino, lower alkylamino, a protected amino, a protected lower alkylamino, hydroxy or lower alkoxy, R2 is hydrogen, acyloxy, pyridium or a heterocyclicthio group which may have suitable substituent(s), R3 is carboxy or its derivative, A is carbonyl, hydroxy(lower)alkylene or a protected hydroxy(lower)alkylene and R4 is hydrogen or halogen, or R2 and R3 are linked together to represent a group of the formula -COO-, this divisional application being directed to intermediate compounds of the formula:
-
公开(公告)号:SE8302027L
公开(公告)日:1983-04-12
申请号:SE8302027
申请日:1983-04-12
Applicant: FUJISAWA PHARMACEUTICAL CO
IPC: A61K31/545 , A61K31/546 , A61P31/04 , C07D277/20 , C07D277/32 , C07D277/34 , C07D277/38 , C07D277/40 , C07D277/44 , C07D277/46 , C07D277/48 , C07D277/52 , C07D501/20 , C07D501/22 , C07D501/34 , C07D501/36 , C07D277/42
Abstract: Antibiotic cephalosporin compounds, method of making and pharmaceutical composition thereof represented by the general formula wherein R1 is amino, lower alkylamino, a protected amino, a protected lower alkylamino, hydroxy or lower alkoxy, R2 is hydrogen, acyloxy, pyridium or a heterocyclicthio group which may have suitable substituent(s), R3 is carboxy or its derivative, A is carbonyl, hydroxy(lower)alkylene or a protected hydroxy(lower)alkylene and R4 is hydrogen or halogen, or R2 and R3 are linked together to represent a group of the formula -COO-, this divisional application being directed to intermediate compounds of the formula:
-
公开(公告)号:DK249681A
公开(公告)日:1981-12-19
申请号:DK249681
申请日:1981-06-04
Applicant: FUJISAWA PHARMACEUTICAL CO
IPC: C07C17/26 , C07D257/04 , C07D285/08 , C07D295/21 , C07D501/24 , C07D501/46 , C07D
-
公开(公告)号:DK101477A
公开(公告)日:1977-09-10
申请号:DK101477
申请日:1977-03-08
Applicant: FUJISAWA PHARMACEUTICAL CO
IPC: A61K31/545 , A61K31/546 , A61P31/04 , C07D277/20 , C07D277/32 , C07D277/34 , C07D277/38 , C07D277/40 , C07D277/44 , C07D277/46 , C07D277/48 , C07D277/52 , C07D501/20 , C07D501/22 , C07D501/34 , C07D501/36 , C07D
Abstract: Antibiotic cephalosporin compounds, method of making and pharmaceutical composition thereof represented by the general formula wherein R1 is amino, lower alkylamino, a protected amino, a protected lower alkylamino, hydroxy or lower alkoxy, R2 is hydrogen, acyloxy, pyridium or a heterocyclicthio group which may have suitable substituent(s), R3 is carboxy or its derivative, A is carbonyl, hydroxy(lower)alkylene or a protected hydroxy(lower)alkylene and R4 is hydrogen or halogen, or R2 and R3 are linked together to represent a group of the formula -COO-, this divisional application being directed to intermediate compounds of the formula:
-
公开(公告)号:DK276582A
公开(公告)日:1982-12-23
申请号:DK276582
申请日:1982-06-18
Applicant: FUJISAWA PHARMACEUTICAL CO
IPC: C07D213/61 , C07D213/70 , C07D213/73 , C07D285/08 , C07D501/36 , C07D
Abstract: New cephem compounds of the formula: … … wherein… R is amino or a protected amino group;… R is hydrogen, lower aliphatic hydrocarbon group which may be substituted with suitable substituent(s), cyclo(lower)alkyl, or cyclo(lower)alkenyl;… R is lower alkyl which mad be substituted with suitable substituents(s);… R is hydrogen, lower alkyl or amino; and R is hydrogen or lower alkyl; and… pharmaceutically acceptable salts thereof, and processes for their preparation and a pharmaceutical antibacterial composition comprising them in association with a pharmaceutical antibacterial composition comprising a compound of claim 1 in association with a pharmaceutically acceptable, substantially non-toxic carrier or excipient.
-
公开(公告)号:AU7144281A
公开(公告)日:1981-12-24
申请号:AU7144281
申请日:1981-06-09
Applicant: FUJISAWA PHARMACEUTICAL CO
IPC: C07D501/46 , A61K20060101 , A61K31/545 , A61K31/546 , A61P31/04 , C07D20060101 , C07D501/24
-
-
-
-
-
-
-
-
-